Journal: Mucosal Immunology
Article Title: Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis
doi: 10.1016/j.mucimm.2026.01.012
Figure Lengend Snippet: IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Article Snippet: Protein levels of IL-36α/IL-1F6 (R&D Systems; #DY1078-05), IL-36γ/IL-1F9 (Adipogen Life Sciences; #AG-46B-0010), and CXCL10/IP-10 (R&D Systems; #DY266) were measured using commercial ELISA kits.
Techniques: Expressing, Isolation, Infection, Gene Expression, Transcriptomics, Concentration Assay, MANN-WHITNEY